Aviso Wealth Management Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aviso Wealth Management lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 402 shares of the medical equipment provider’s stock after selling 28 shares during the period. Aviso Wealth Management’s holdings in Intuitive Surgical were worth $210,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Howard Capital Management Group LLC lifted its stake in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. raised its position in shares of Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after acquiring an additional 9,194 shares during the period. Quest Partners LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $173,000. Great Valley Advisor Group Inc. grew its position in shares of Intuitive Surgical by 2.7% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $1,249,000 after acquiring an additional 66 shares during the period. Finally, Algert Global LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $1,988,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 2.2 %

Shares of ISRG opened at $519.81 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market cap of $185.15 billion, a P/E ratio of 81.09, a PEG ratio of 5.85 and a beta of 1.43. The firm’s 50 day moving average price is $561.24 and its 200 day moving average price is $532.59.

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.